Pharmaceutical Executive

🚨Our December issue is LIVE🚨 A Rocky Road for Regulation 🔷 DTC's New Era of Engagement 🔷 Seeking More Value, Less Cost 🔷 Margaret Keegan, the new CEO of Precision Medicine Group shares Pharma's Best Kept Secret 🔷 and so much more right here! ➡️ https://lnkd.in/dq4PvaR7

📹 Nancy Ghattas, VP, US franchise head, imunno-oncology, gastrointestinal tumors, AstraZeneca, discusses the promising results from the ADRIATIC trial, in which patients were treated with Imfinzi for limited-stage #smallcelllungcancer

Due to the rising influence of payers in the US healthcare system, today’s pharma commercial teams have a more significant influence on clinical trial and real-world evidence study design than ever before. To be an effective partner to the clinical and scientific teams tasked with managing these trials and studies, commercial professionals must understand precisely what payers need and how to generate the data that will build a value story that is meaningful to them. How training can help: Educating teams on foundational elements of coverage criteria and trial/study design creates a richer understanding of what payers want and how to give it to them. To be comprehensive, training should also include deep dives into fiscal efficiencies, endpoint nuances, and how to maximize the value of a pipeline. Read more about overcoming six common pain points troubling pharma in 2025 in this Pharmaceutical Executive article by Diane Petrone: https://lnkd.in/exHGsPEB #pharma #biotech #traininganddevelopment #marketaccess #elevateandaccelerate #rwe #realworldevidence #clinicaltrials

Calling all rising stars in pharma and biotech! The 2025 Emerging Pharma Leaders Awards are here to celebrate the next generation of trailblazers shaping the future of our industry. Nominate yourself or someone you admire who embodies leadership, innovation, and vision. Are they c-suite bound? Do they inspire others while navigating the complexities of R&D, marketing, sales, or market access? This is your chance to spotlight the leaders of tomorrow. Submit your nomination today: https://ow.ly/4qgm50UOZ4e #PharmaLeaders #EmergingLeaders #PharmaInnovation

The European Medicines Agency’s Committee for Medicinal Products for Human Use recently issued a positive opinion for the use of #Omvoh for the treatment of moderate to severe Crohn’s in adults. Mark Genovese, MD, senior vice president at Eli Lilly and Company Immunology Development, spoke with Pharmaceutical Executive about the importance of developing medicines that treat disruptive symptoms of chronic conditions.

📹 Paul Howe, chief commercial officer at Protega Pharmaceuticals, discusses recent rule changes and how the industry is impacted by them.

Prescription data between 2017 and 2023 revealed that while #Adderall prescription fills decreased following the shortage, many children transitioned to alternative stimulants for attention-deficit/hyperactivity disorder.

In the United States, the #biomedical industry encounters numerous #regulatory challenges in conducting nonclinical and clinical studies and managing chemistry, manufacturing, and controls (CMC) activities.🖊️Navneet K., senior manager of regulatory affairs, Alkermes

Health In Tech is teaming up with Vitable Health and Marpai Administrators LLC on the project.